Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.123.032835 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Frank Geurts und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Erasmus Medical Center University Medical Center Rotterdam Rotterdam The Netherlands. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Kidney Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background Inhibition of prostaglandin synthesis by nonsteroidal anti‐inflammatory drugs is associated with cardiovascular mortality and kidney disease. This study hypothesizes that urinary prostaglandin E2 (PGE2) and PGE2 metabolite (PGEM) excretions are markers of cardiovascular and kidney health, because they reflect both systemic and kidney‐derived PGE2 production. Methods and Results PGE2 and PGEM were measured in spot urine samples from 2291 participants (≥55 years old) of the population‐based Rotterdam Study. Urinary PGE2 and PGEM excretions were analyzed using linear regression analyses to identify cross‐sectional associations with cardiovascular risk factors and baseline estimated glomerular filtration rate (eGFR). Longitudinal associations with cardiovascular mortality and kidney outcomes (eGFR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Erasmus Medical Center University Medical Center Rotterdam Rotterdam The Netherlands.
- Department of Epidemiology, Erasmus Medical Center University Medical Center Rotterdam Rotterdam The Netherlands.
- Department of Clinical Epidemiology, Department of Clinical Medicine Aarhus University Hospital and Aarhus University Aarhus Denmark.
- Department of Biomedicine Aarhus University Aarhus Denmark.
ORCID-Profile: Frank Geurts, Layal Chaker, Anna C van der Burgh, Deirdre Cronin-Fenton, Robert A Fenton, Ewout J Hoorn
Zitieren
APA
Geurts, F., Chaker, L., van der Burgh, A. C., Cronin-Fenton, D., Fenton, R. A., & Hoorn, E. J. (2024). Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.032835
Vancouver
Geurts F, Chaker L, van der Burgh AC, Cronin-Fenton D, Fenton RA, Hoorn EJ. Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.032835
BibTeX
@article{Geurts2024,
author = {Geurts, Frank and Chaker, Layal and van der Burgh, Anna C and Cronin-Fenton, Deirdre and Fenton, Robert A and Hoorn, Ewout J},
title = {Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.123.032835}
}
EUVIMED